Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12606803 | Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12605443 | SAR-CoV-2 DNA vaccine and method of administering thereof | 🖼🧊📄§ | 2026-04-21 | 2041-10-13 | 0 | 31 |
| 12605395 | Materials and methods for immunosuppressive tumor microenvironment-targeted cancer therapy | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605445 | Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer | 🖼🧊📄§ | 2026-04-21 | 2044-01-12 | 0 | 31 |
| 12605399 | Compositions for CFTR MRNA therapy | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12605452 | Compounds that degrade kinases and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-03 | 0 | 31 |
| 12606523 | Deuterated organic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605331 | Composition comprising iris-derived exosome as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2043-12-27 | 0 | 31 |
| 12605402 | Therapeutic uses of oxidizing hypotonic acid solutions | 🖼🧊📄§ | 2026-04-21 | 2040-07-02 | 0 | 31 |
| 12605366 | Telmisartan for the treatment of hypertension in dogs | 🖼🧊📄§ | 2026-04-21 | 2040-04-30 | 0 | 31 |
| 12605446 | PSMA-targeted immunotherapies for cancers | 🖼🧊📄§ | 2026-04-21 | 2041-08-20 | 0 | 31 |
| 12605367 | Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies | 🖼🧊📄§ | 2026-04-21 | 2040-09-15 | 0 | 31 |
| 12605414 | Discovery of novel Akkermansia muciniphila AK32 and application thereof for improving intestinal function | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12606598 | Chimeric klebicins | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12605332 | Transdermal delivery formulations | 🖼🧊📄§ | 2026-04-21 | 2042-10-31 | 0 | 31 |
| 12606796 | Delivery of oncolytic viruses using dendritic cells | 🖼🧊📄§ | 2026-04-21 | 2040-05-07 | 0 | 31 |
| 12605412 | Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments | 🖼🧊📄§ | 2026-04-21 | 2040-09-29 | 0 | 31 |
| 12605355 | HA-paclitaxel conjugate for treatment of mesothelioma | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12606558 | Condensed pyrazole derivatives as inhibitors of SARM1 | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12606594 | Heterotandem bicyclic peptide complexes | 🖼🧊📄§ | 2026-04-21 | 2042-02-02 | 0 | 31 |
| 12606610 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | 🖼🧊📄§ | 2026-04-21 | 2043-08-16 | 0 | 31 |
| 12606607 | T cell receptors | 🖼🧊📄§ | 2026-04-21 | 2042-10-13 | 0 | 31 |
| 12606609 | Polypeptides having improved properties | 🖼🧊📄§ | 2026-04-21 | 2041-01-26 | 0 | 31 |
| 12606606 | Nucleic acid construct that encodes chimeric rhodopsin | 🖼🧊📄§ | 2026-04-21 | 2040-09-11 | 0 | 31 |
| 12606617 | Composition comprising an IgE antibody | 🖼🧊📄§ | 2026-04-21 | 2041-04-23 | 0 | 31 |
| 12606613 | Humanized anti-C5a antibodies | 🖼🧊📄§ | 2026-04-21 | 2041-05-06 | 0 | 31 |
| 12606616 | PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer | 🖼🧊📄§ | 2026-04-21 | 2045-12-08 | 0 | 31 |
| 12606625 | Antibody binding specifically to B7—H3 and use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-07-08 | 0 | 31 |
| 12606633 | Methods and compositions for anti-CD73 antibodies and variants | 🖼🧊📄§ | 2026-04-21 | 2042-01-25 | 0 | 31 |
| 12606634 | Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 | 🖼🧊📄§ | 2026-04-21 | 2044-04-08 | 0 | 31 |
| 12606805 | Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents | 🖼🧊📄§ | 2026-04-21 | 2043-08-29 | 0 | 31 |
| 12606825 | Compositions and methods for modulating RPGR expression | 🖼🧊📄§ | 2026-04-21 | 2041-03-04 | 0 | 31 |
| 12606571 | Macrocyclic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-04-09 | 0 | 31 |
| 12606552 | Bifunctional compound, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-04-21 | 2042-09-09 | 0 | 31 |
| 12606827 | Compounds for treatment of osteoarthritis | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12606619 | Human monoclonal antibodies against TIGIT for immune related diseases | 🖼🧊📄§ | 2026-04-21 | 2041-06-23 | 0 | 31 |
| 12606620 | Anti-LILRB1 antibody and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-27 | 0 | 31 |
| 12606639 | Antigen binding proteins | 🖼🧊📄§ | 2026-04-21 | 2045-05-20 | 0 | 31 |
| 12599554 | Pharmaceutical formulations comprising tadalafil | 🖼🧊📄§ | 2026-04-14 | 2041-07-28 | 0 | 31 |
| 12599588 | Inhibitor for V-ATPase activity, antibacterial agent, medicine, antibacterial method and screening method | 🖼🧊📄§ | 2026-04-14 | 2040-01-15 | 0 | 31 |
| 12599596 | Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof | 🖼🧊📄§ | 2026-04-14 | 2044-11-21 | 0 | 31 |
| 12599698 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599648 | Pharmaceutical composition comprising a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain fatty acid or prodrug thereof | 🖼🧊📄§ | 2026-04-14 | 2040-06-30 | 0 | 31 |
| 12599654 | Immunogenic peptide fragments of metalloprotease ADAMTS-7 and uses thereof in anti-atherosclerosis and related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-08-20 | 0 | 31 |
| 12599674 | Conjugates, their compositions, and their related methods | 🖼🧊📄§ | 2026-04-14 | 2045-06-24 | 0 | 31 |
| 12599630 | Serum exosome with high osteogenesis and high angiogenesis, preparation method, and application thereof | 🖼🧊📄§ | 2026-04-14 | 2042-10-12 | 0 | 31 |
| 12599628 | Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-28 | 0 | 31 |
| 12600945 | Human Vγ9Vδ2T cell proliferation culture method and culture medium | 🖼🧊📄§ | 2026-04-14 | 2039-02-19 | 0 | 31 |
| 12600757 | Peptides inhibiting gamma-c-cytokine activity and methods of use | 🖼🧊📄§ | 2026-04-14 | 2038-04-04 | 0 | 31 |
| 12600702 | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-13 | 0 | 31 |